5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases

Inclusion Criteria: * Any solid tumors are eligible. Lymphoma, myeloma and germ cell tumors are excluded. * Histological confirmation of neoplastic disease either from original primary or metastatic sites is required. * Radiological diagnosis of oligometastastic metastatic disease is accepted if considered clinically acceptable. Histological confirmation is not mandatory. * Oligometastatic disease, maximum of 5 lesions. * At least one lesion is suitable for stereotactic body radiotherapy * All known sites of disease have plans for local ablative management (see section management plan for definitions) within 3 months * ECOG ≤ 2 * At least 18 yrs old Exclusion Criteria: * Previous radiotherapy to the intended treatment site * Patient cannot tolerate physical set up required for SBRT * Active bowel obstruction, if treating abdominal/pelvic site * Chemotherapy within 2 weeks of intended radiation therapy * Treatment plan respecting normal tissue tolerances using dose fractionation specified within the protocol cannot be achieved * Pregnancy